Search Results

From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics years of drug discovery research in the pharmaceutical industry, where he works mainly on GPCRs as therapeutic He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general

Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy , and how understanding receptor activity in acidic micro environments could unlock new therapeutic strategies

protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics

. 💊 Therapeutic Potential : Understanding bias enables researchers to design drugs that target specific Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes

of GPCRs in disease states to help test the feasibility of using protein-targeted degradation as a therapeutic

molecular explanation of small molecules for their pre-clinical efficacy and to support the design of novel therapeutics

Keyvan Sedaghat discussing how GPCR function is shaped by lipid raft compartmentalization, the expanding therapeutic efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel therapeutic

the company's ability to predict the residence time of a ligand and its potential correlation with a therapeutic Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about the importance of gaining more information about the therapeutic effect in patients or animals and the They also shared their preference for small molecule therapies over protein therapeutics.

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes

Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University

biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological tools and potential therapeutic

We hope our research will aid in the development of new therapeutic interventions for the alleviation

Introduction Drug discovery pipelines increasingly depend on screening platforms designed to identify therapeutically

He is also an Associate Leader of the Experimental Therapeutics and Metabolism Program and the Director

clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics

Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

She has advanced the use of computational methods to meet the challenges of designing therapeutics with

As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic

Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics

His research focuses on developing computational pipelines for rational ligand design targeting therapeutically

nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).